Sun Pharma acquires US-based Pharmalucence

Tags: Companies
Drug major Sun Pharmaceutical Industries has acquired US-based Pharmalucence Inc for an undisclosed amount.

Pharmalucence, which has sterile injectable capacity in the US, has been acquired by one of the subsidiaries of Sun Pharma, the Mumbai-based firm said in a statement today.

The company, however, did not disclose the financial details of the deal.

Earlier this year, Sun Pharma had acquired Ranbaxy Laboratories in an all-stock transaction with a total equity value of $3.2 billion along with debt of $800 million, taking the overall deal value to $4 billion.

Sun Pharma shares were trading at Rs 748.30, up 1.30 per cent from its previous close.


  • India moving just one rank on ease of doing business is an eye opener

    Narendra Modi government’s disappointment on 130th ranking assigned to India on ‘ease of doing business’ by the International Finance Corporatio


Stay informed on our latest news!


BK Chaturvedi

Why is India doing badly on hunger?

Health of its young is a vital policy issue for ...

Rajgopal Nidamboor

Perceiving is more than what meets the eye

Philosopher Aristotle emphasised the fact that “thinking always involves thinking ...

Shona Adhikari

Owais Husain searches for a lost homeland

The seventh edition of the Mumbai Public Art Festival (PAF) ...